Article contents
Vigabatrin
Published online by Cambridge University Press: 18 December 2001
Abstract
The new antiepileptic drugs introduced over the last decade provide a welcome increase in the therapeutic options available for the 25% of children with epilepsy who remain refractory to traditional therapy. In the mid 1980s, vigabatrin (VGB) was the first of these to be made available in clinical practice. In 1997, the visual field deficits reported in association with VGB prompted a review of its place in the management of epilepsy. We provide an overview of the uses of VGB and a discussion of the difficulties which currently affect our clinical practice.
- Type
- Annotation
- Information
- Copyright
- © 2001 Mac Keith Press
- 9
- Cited by